Legal & Disclaimers

Published by DrugMarkup.com

At DrugMarkup, our mission is to expose unjustifiable price inflation in the pharmaceutical industry through transparent data and public education. In pursuit of that mission, we are obliged to state the following disclaimers and clarifications regarding the nature, scope, and limitations of the content provided on this website.

---

📌 1. Medical Disclaimer

The content provided by DrugMarkup is intended strictly for educational and informational purposes. It does not constitute medical advice, diagnosis, or treatment, nor is it a substitute for consultation with licensed healthcare professionals. Always seek the advice of a qualified medical practitioner with any questions you may have regarding a health condition, diagnosis, or prescribed medication.

📌 2. Drug Pricing Disclaimer

The drug prices displayed on this platform are approximations derived from publicly available data and reputable pricing databases. These may include:

• U.S. retail cash prices (e.g., GoodRx, Drugs.com)
• Government price listings (e.g., CMS NADAC, UK NHS Drug Tariff)
• International procurement databases (e.g., WHO, MSH, Canadian formulary)

Actual prices may vary widely depending on location, dosage form, pharmacy, insurance status, and negotiation agreements. All prices should be considered indicative, not definitive.

📌 3. Manufacturing Cost Disclaimer

All manufacturing costs presented on DrugMarkup are estimates based on credible academic research and global procurement benchmarks. These include:

• Peer-reviewed studies by Dr Andrew Hill (University of Liverpool)
• Reports from Médecins Sans Frontières (MSF) and Health Action International (HAI)
• International procurement indices (e.g., MSH Drug Price Guide, PharmaCompass API data)

These figures represent mass-production cost estimates, and do not include R&D, marketing, regulatory compliance, or administrative overheads. They are used for the sole purpose of illustrating the markup ratio between production cost and patient-facing price.

📌 4. Educational Purpose Disclaimer

All material on this site is offered in good faith for the public benefit, and is intended solely to inform and empower consumers, researchers, and policymakers. We make no warranties or guarantees regarding the completeness, timeliness, or accuracy of any data presented. All content is subject to change without notice. Visitors use the information at their own discretion and risk.

📌 5. Financial and Investment Disclaimer

DrugMarkup does not provide financial or investment advice. Any reference to pharmaceutical companies, their revenue, lobbying activity, or share performance is presented exclusively for context, transparency, and accountability. No part of this site should be interpreted as a recommendation to buy, sell, or hold any financial instruments.

📌 6. Copyright & Fair Use

Some material on this site may quote, excerpt, or visually reproduce content from third-party sources under the doctrine of fair use, as defined in Section 107 of the U.S. Copyright Act. These include, but are not limited to: government reports, academic publications, corporate financial disclosures, and journalistic investigations. Such usage is intended for commentary, criticism, news reporting, research, and education. All rights remain with the original copyright holders.

📌 7. Source Attribution & Transparency

DrugMarkup strives to use only verifiable, publicly accessible data wherever possible. Our principal sources include:

• GoodRx
• Drugs.com
• CMS NADAC Database
• World Health Organization (WHO)
• Médecins Sans Frontières (MSF)
• Public Citizen
• University of Liverpool (Hill et al.)
• PharmaCompass
• National formularies of Canada, UK (NHS), Germany (Lauer-Taxe), and India (NPPA)

We welcome academic collaboration and encourage visitors to contact us with source inquiries, corrections, or updates. Transparency is the bedrock of our work.